Seeking Alpha

Boston Scientific WATCHMAN FLX™ Left Atrial Appendage Closure Device Demonstrates Superior Bleeding Risk Reduction to Oral Anticoagulation Following a Cardiac Ablation in the ...

Data also demonstrates that the stroke risk reduction device is as effective as oral anticoagulants for patients with atrial fibrillation following a cardiac ablation The trial met the primary safety ...
Seeking Alpha

Boston Scientific Announces FDA Approval for the Latest-Generation WATCHMAN FLX™ Pro Left Atrial Appendage Closure Device

New stroke risk reduction therapy with thromboresistant coating is designed to advance procedural performance and safety MARLBOROUGH, Mass., Sept. 6, 2023 /PRNewswire/ -- Boston Scientific Corporation ...
Healio

Left atrial appendage closure safe, effective first-line option for AF ablation patients

Please provide your email address to receive an email when new articles are posted on . OPTION is a head-to-head trial of left atrial appendage closure with Watchman FLX vs. anticoagulation after ...
The American Journal of Managed Care

Q&A: Oussama Wazni Speaks to OPTION Trial, Potential of Watchman FLX in Atrial Fibrillation

The OPTION trial showed equivalence between Watchman FLX and oral anticoagulation in preventing stroke, systemic embolism, and all-cause death post-ablation. Subgroup analyses revealed consistent ...
TCTMD

TCT 535: Watchman Left Atrial Appendage Occlusion Peri-Device Leaks With Elevated Mean Left Atrial Pressure Associated With Clinical Outcomes (WATCH-OUT) Study

Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...
Healio

Concomitant left atrial appendage occlusion, TAVR an option for some with AF: WATCH-TAVR

Please provide your email address to receive an email when new articles are posted on . Atrial fibrillation is associated with increased risk for bleeding and stroke in patients undergoing TAVR. Left ...
The Greeley Tribune

New stroke-reducing device available at North Colorado Medical Center for atrial fibrillation patients

A new device is helping Greeley patients with irregular heartbeats live with a reduced risk of stroke and a greater quality of life. In May, Banner Health’s North Colorado Medical Center became one of ...
AOL

MCH updates WATCHMAN procedures with new device

Apr. 9—Medical Center Hospital is proud to announce that Dr. Manohar Angirekula, Dr. Adam Farber and Dr. Fernando Boccalandro successfully implanted the first WATCHMAN FLX Pro Device on April 1. MCH ...
TCTMD

TCT 1511: Closure of a Peri-Device Leak After Left Atrial Appendage Closure With Watchman Using an Amulet Device

TCT 489: The Comparison of Tissue Characteristics of Restenosis After Coronary Interventions: Insights From a Histological Analysis After Directional Coronary Atherectomy Receive the the latest news, ...

Left Atrial Appendage Closure Devices Market 2025-2033: Demand Forecast, Regional Insights, Company Profiles – Astute Analytica

The global left atrial appendage closure (LAAC) devices market is projected to register a robust growth from 2025 to 2033.
Medscape

Cardiostim: Left Atrial Appendage Occlusion Done the Right Way

On the first day of the 2016 CardioStim sessions, I am happy to report a "positive" study on percutaneous left atrial appendage closure [1]. Notice I did not write Watchman. In Europe, the majority of ...